|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Munagala R, Kausar H, Munjal C and Gupta
RC: Withaferin A induces p53-dependent apoptosis by repression of
HPV oncogenes and upregulation of tumor suppressor proteins in
human cervical cancer cells. Carcinogenesis. 32:1697–1705. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zur Hausen H: Papillomaviruses and cancer:
From basic studies to clinical application. Nat Rev Cancer.
2:342–350. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Moody CA and Laimins LA: Human
papillomavirus oncoproteins: Pathways to transformation. Nat Rev
Cancer. 10:550–560. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Woodman CB, Collins SI and Young LS: The
natural history of cervical HPV infection: Unresolved issues. Nat
Rev Cancer. 7:11–22. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang X, Wang HK, McCoy JP, Banerjee NS,
Rader JS, Broker TR, Meyers C, Chow LT and Zheng ZM: Oncogenic HPV
infection interrupts the expression of tumor-suppressive miR-34a
through viral oncoprotein E6. RNA. 15:637–647. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hu T, Li YS, Chen B, Chang YF, Liu GC,
Hong Y, Chen HL and Xiyang YB: Elevated glucose-6-phosphate
dehydrogenase expression in the cervical cancer cases is associated
with the cancerigenic event of high-risk human papillomaviruses.
Exp Biol Med (Maywood). 240:1287–1297. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Salimi A, Paeezi M, Yousefsani BS, Shadnia
S, Hassanian-Moghaddam H, Zamani N and Pourahmad J: Inhibition of
glucose-6-phosphate dehydrogenase protects hepatocytes from
aluminum phosphide-induced toxicity. Pestic Biochem Physiol.
143:141–146. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Polat MF, Taysi S, Gul M, Cikman O, Yilmaz
I, Bakan E and Erdogan F: Oxidant/antioxidant status in blood of
patients with malignant breast tumour and benign breast disease.
Cell Biochem Funct. 20:327–331. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hu T, Zhang C, Tang Q, Su Y, Li B, Chen L,
Zhang Z, Cai T and Zhu Y: Variant G6PD levels promote tumor cell
proliferation or apoptosis via the STAT3/5 pathway in the human
melanoma xenograft mouse model. BMC Cancer. 13:2512013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pes GM, Bassotti G and Dore MP: Colorectal
cancer mortality in relation to glucose − 6 - phosphate
dehydrogenase deficiency and consanguinity in Sardinia: A spatial
correlation analysis. Asian Pac J Cancer Prev. 18:2403–2407.
2017.PubMed/NCBI
|
|
12
|
Giatromanolaki A, Sivridis E, Arelaki S
and Koukourakis MI: Expression of enzymes related to glucose
metabolism in non-small cell lung cancer and prognosis. Exp Lung
Res. 43:167–174. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hu T, Chang YF, Xiao Z, Mao R, Tong J,
Chen B, Liu GC, Hong Y, Chen HL, Kong SY, et al: miR-1 inhibits
progression of high-risk papillomavirus-associated human cervical
cancer by targeting G6PD. Oncotarget. 7:86103–86116. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ambros V and Lee RC: Identification of
microRNAs and other tiny noncoding RNAs by cDNA cloning. Methods
Mol Biol. 265:131–158. 2004.PubMed/NCBI
|
|
15
|
Gimpel C, Avni FE, Bergmann C, Cetiner M,
Habbig S, Haffner D, König J, Konrad M, Liebau MC, Pape L, et al:
Perinatal diagnosis, management, and follow-up of cystic renal
diseases: A clinical practice recommendation with systematic
literature reviews. JAMA Pediatr. 172:74–86. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pan X, Wang Z, Wan B and Zheng Z:
MicroRNA-206 inhibits the viability and migration of
medulloblastoma cells by targeting LIM and SH3 protein 1. Exp Ther
Med. 14:3894–3900. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pang C, Huang G, Luo K, Dong Y, He F, Du
G, Xiao M and Cai W: miR-206 inhibits the growth of hepatocellular
carcinoma cells via targeting CDK9. Cancer Med. 6:2398–2409. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu F, Zhao X, Qian Y, Zhang J, Zhang Y
and Yin R: MiR-206 inhibits head and neck squamous cell carcinoma
cell progression by targeting HDAC6 via PTEN/AKT/mTOR pathway.
Biomed Pharmacother. 96:229–237. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
FIGO Committee on Gynecologic Oncology, .
FIGO staging for carcinoma of the vulva, cervix, and corpus uteri.
Int J Gynaecol Obstet. 125:97–98. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rob L, Halaska M and Robova H:
Nerve-sparing and individually tailored surgery for cervical
cancer. Lancet Oncol. 11:292–301. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pandima Devi K, Rajavel T, Daglia M,
Nabavi SF, Bishayee A and Nabavi SM: Targeting miRNAs by
polyphenols: Novel therapeutic strategy for cancer. Semin Cancer
Biol. 46:146–157. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Muluhngwi P and Klinge CM: Identification
of miRNAs as biomarkers for acquired endocrine resistance in breast
cancer. Mol Cell Endocrinol. 456:76–86. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chuanyin L, Xiaona W, Zhiling Y, Yu Z,
Shuyuan L, Jie Y, Chao H, Li S, Hongying Y and Yufeng Y: The
association between polymorphisms in microRNA genes and cervical
cancer in a Chinese Han population. Oncotarget. 8:87914–87927.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Manikandan J, Aarthi JJ, Kumar SD and
Pushparaj PN: Oncomirs: The potential role of non-coding microRNAs
in understanding cancer. Bioinformation. 2:330–334. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yin K, Yin W, Wang Y, Zhou L, Liu Y, Yang
G, Wang J and Lu J: MiR-206 suppresses epithelial mesenchymal
transition by targeting TGF-β signaling in estrogen receptor
positive breast cancer cells. Oncotarget. 7:24537–24548.
2016.PubMed/NCBI
|
|
29
|
Yan B, Zhu CD, Guo JT, Zhao LH and Zhao
JL: miR-206 regulates the growth of the teleost tilapia
(Oreochromis niloticus) through the modulation of IGF-1 gene
expression. J Exp Biol. 216:1265–1269. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ling S, Ruiqin M, Guohong Z, Bing S and
Yanshan C: Decreased microRNA-206 and its function in cervical
cancer. Eur J Gynaecol Oncol. 36:716–721. 2015.PubMed/NCBI
|
|
31
|
Gao LP, Cheng ML, Chou HJ, Yang YH, Ho HY
and Chiu DT: Ineffective GSH regeneration enhances G6PD-knockdown
Hep G2 cell sensitivity to diamide-induced oxidative damage. Free
Radic Biol Med. 47:529–535. 2009. View Article : Google Scholar : PubMed/NCBI
|
